AZ-VUB [clinicaltrials_resource:718462941105be59ce9677080955d6b7]
Jacques De Grève, MD PhD [clinicaltrials_resource:0113ef457ed615842f7d27ba71a460fa]Samuel Bral, MD [clinicaltrials_resource:0d0cec3105979abbcd00e09752ebf203]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Jacques De Grève, MD PhD [clinicaltrials_resource:2e1eb0d77d235e428265605600e14a6d]Bart Keymeulen, MD, PhD [clinicaltrials_resource:33824c73f0328260628b49c7d63868a2]Jacques De Grève, MD PhD [clinicaltrials_resource:4272bece2347f87e42388eed6202669d]Samuel Bral, MD [clinicaltrials_resource:4d5fcd2c049dedeeb749d3076c843c15]Samuel Bral, MD [clinicaltrials_resource:5c9c8eead3bf0605e3a9edec2ec55d65]Jacques De Grève, MD PhD [clinicaltrials_resource:5d093be716106812a275ec55168f323e]Jacques De Grève, MD PhD [clinicaltrials_resource:6ba6f715c37734e50516f3c0d866f397]Jacques De Grève, MD PhD [clinicaltrials_resource:72f1035d842d27474b545314a9127789]Jacques De Grève, MD PhD [clinicaltrials_resource:9babb077cfbe401d525c0d9f7523b8f5]Samuel Bral, MD [clinicaltrials_resource:cc3e047895d3e4cb1a1e81001182063c]Samuel Bral, MD [clinicaltrials_resource:cde4e72212d309c640b8a84a04bcd9aa]Jacques De Grève, MD PhD [clinicaltrials_resource:ff9053105018a5ecc95f2f3321176c6a]
affiliation [clinicaltrials_vocabulary:affiliation]
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene [clinicaltrials:NCT00339586]Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00379717]Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts [clinicaltrials:NCT00409461]Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes [clinicaltrials:NCT00623610]Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients [clinicaltrials:NCT00627146]Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives [clinicaltrials:NCT00654121]clinicaltrials:NCT01379729Beta Cell Function in (Pre)Type 1 Diabetes [clinicaltrials:NCT01402037]
collaborator [clinicaltrials_vocabulary:collaborator]
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene [clinicaltrials:NCT00339586]Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00379717]Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts [clinicaltrials:NCT00409461]Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes [clinicaltrials:NCT00623610]Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients [clinicaltrials:NCT00627146]Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives [clinicaltrials:NCT00654121]Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. [clinicaltrials:NCT00727350]clinicaltrials:NCT00798785Beta Cell Function in (Pre) Type 1 Diabetes [clinicaltrials:NCT00800085]clinicaltrials:NCT01379729Beta Cell Function in (Pre)Type 1 Diabetes [clinicaltrials:NCT01402037]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene [clinicaltrials:NCT00339586]Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00379717]Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts [clinicaltrials:NCT00409461]Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes [clinicaltrials:NCT00623610]Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients [clinicaltrials:NCT00627146]Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives [clinicaltrials:NCT00654121]Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. [clinicaltrials:NCT00727350]clinicaltrials:NCT00798785Beta Cell Function in (Pre) Type 1 Diabetes [clinicaltrials:NCT00800085]clinicaltrials:NCT01379729Beta Cell Function in (Pre)Type 1 Diabetes [clinicaltrials:NCT01402037]
source [clinicaltrials_vocabulary:source]
AZ-VUB [clinicaltrials_resource:718462941105be59ce9677080955d6b7]
Bio2RDF identifier
718462941105be59ce9677080955d6b7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:718462941105be59ce9677080955d6b7
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:718462941105be59ce9677080955d6b7
title
AZ-VUB
@en
type
label
AZ-VUB [clinicaltrials_resource:718462941105be59ce9677080955d6b7]
@en